CPIX — Cumberland Pharmaceuticals Inc · catalysts, narrative & risks

Company Snapshot

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) is a Nashville, Tennessee–based specialty pharmaceutical company, founded in 1999 and IPO'd in 2009 [4], [16]. As of Oct 21, 2026, it trades near ~$8.17 with a market capitalization of roughly $122M, classifying it as a small-cap [14], [15], [16]. Historically focused on branded acute-care/gastroenterology products (e.g., Caldolor, Vaprisol, Kristalose, Sancuso, Acetadote), the company has pivoted to a development-stage biopharmaceutical model centered on its lead candidate ifetroban after selling its commercial business [3], [8], [15], [16].